Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Intrexon Corporation (XON) and Lead Plaintiff Deadline: July 5, 2016

PGEN

NEW YORK / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the Company") (NYSE: XON). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Horsehead securities between May 12, 2014 and April 20, 2016, both dates inclusive (the "Class Period").

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").

The Complaint alleges that certain officers and directors have issued materially false and misleading statements and/or failed to disclose opposing information to investors. On April 21, 2016, Spotlight Research reported about Intrexon that: (1) Intrexon's technology is being questioned by the WHO, CDC and NIH; (2) Intrexon exaggerated its revenues by 50% through dealings with related parties; (3) Intrexon's technology program is just overhyped failed products; and (4) Intrexon is the Theranos of the public markets. Following this news, Intrexon stock dropped $9.73 per share or over 26%, to close at $27.10 per share on April 21, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint and join the action, visit the firm's website: http://www.bgandg.com/#!xon/pj7k7. To discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Intrexon you have until July 5, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today